Form 4: Lam Research Director Boosts Stake with Stock Acquisition

Sentiment:

Insider Transaction Report


Lam Research Director Michael R. Cannon acquired 1,635 shares of common stock on November 7, 2025, increasing his beneficial ownership to 191,375 shares.

Summary

  • Michael R. Cannon, a Director of Lam Research Corp (LRCX), acquired 1,635 shares of common stock.
  • The transaction occurred on November 7, 2025, and was made pursuant to a Rule 10b5-1 plan.
  • Following this acquisition, Cannon's total beneficial ownership in Lam Research Corp stands at 191,375 shares.
  • The reported beneficial ownership includes shares subject to unvested restricted stock units.
  • The acquisition price per share was $0, indicating a grant or award rather than a market purchase.

Sentiment

Score: 6

Explanation: The acquisition of additional shares by a director, even if a grant, generally signals confidence in the company's future prospects, contributing to a slightly positive sentiment.

Positives

  • A Director, Michael R. Cannon, increased his beneficial ownership in Lam Research Corp by acquiring 1,635 shares of common stock, which can signal confidence in the company's future.
  • The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned and systematic approach to equity management.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders may interpret the director's increased stake as a positive signal of confidence in the company's long-term performance and strategic direction.

Key Dates

DateDescription
11/07/2025Date of transaction for the acquisition of 1,635 shares of common stock.
11/10/2025Date the Form 4 was signed and filed.

Recommendation

hold

The acquisition of shares by a director, even if a grant, can be interpreted as a positive signal of confidence in the company's long-term prospects. However, a single insider transaction typically does not warrant a change in investment recommendation without further fundamental analysis of the company's financial health and market position.

Keywords

Lam Research, LRCX, Form 4, insider transaction, director, stock acquisition, beneficial ownership, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.